spending – Talk Bio

Actionable Insights Powered by AI

UK Proposes Raising Payment Scheme for Branded Medicines to Nearly 25% Amid Industry Pushback

2 weeks ago talkbio0Tagged Consultation, drugmakers, Industry, Nance-Horan syndrome, payment, pharmaceutical rebates, Pricing, Response process, spending, statutory scheme, UK

UK medicine pricing; NHS spending; statutory scheme; drugmakers; payment percentage; pharmaceutical rebates; industry response; consultation 2025

Prothena Halts Drug and Plans Major Layoffs After Second Rare Disease Trial Failure

5 months ago talkbio0Tagged AL, birtamimab, business options, drug failure, layoffs, Phase 3 Clinical Trials, Primary amyloidosis, Prothena, spending

Prothena; birtamimab; AL amyloidosis; Phase III trial; drug failure; layoffs; biotech; spending cuts; business options

Charles River Laboratories Forecasts Revenue Decline in 2025 Amid CDMO Challenges

9 months ago talkbio0Tagged 2025, Biopharma, business career, CDMO, Charles, constraints, Drug Industry, IL31RA gene, revenue outlook, River Laboratories, spending, trends qualifier

Charles River Laboratories, CRL, 2025 revenue outlook, CDMO business challenges, biopharma spending constraints, pharmaceutical industry trends

Congress Eyes Major PBM Reforms in Year-End Spending Bill

10 months ago talkbio0Tagged Benefit Managers, bipartisan, Congress, Congress (U.S. Legislature), Health care facility, Legislation, PBMs, Pharmaceutical Services, Pharmacy Benefit Manager, Prices, reforms, spending, year-end

Pharmacy Benefit Managers (PBMs), PBM reforms, healthcare costs, year-end spending bill, Congress, bipartisan legislation, transparency, drug prices.